TY  - CONF

T1  - Effector cell-mediated mechanisms play the dominant role in the cytotoxicity of Rituximab on human peripheral blood B cells from normal donors and patients with chronic lymphocytic leukemia.

JO  - BLOOD

PY  - 2000/11/16

AU  - Voso MT

AU  - Pantel G

AU  - Rutella S

AU  - Weis M

AU  - Urbano R

AU  - Leone G

AU  - Haas R

AU  - Hohaus S

ED  - 

VL  - 96

IS  - 11

SP  - 338A

EP  - 339A

Y2  - 2026/02/25

ER  -